SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-132585
Filing Date
2024-05-07
Accepted
2024-05-07 07:38:34
Documents
15
Period of Report
2024-05-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d823090d8k.htm   iXBRL 8-K 23236
2 EX-99.1 d823090dex991.htm EX-99.1 29471
6 GRAPHIC g823090dsp4.jpg GRAPHIC 8573
  Complete submission text file 0001193125-24-132585.txt   200137

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20240507.xsd EX-101.SCH 2838
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20240507_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20240507_pre.xml EX-101.PRE 11699
18 EXTRACTED XBRL INSTANCE DOCUMENT d823090d8k_htm.xml XML 3756
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 24919642
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)